Insiders | Shares | % | Avg Price | Total $ | |
---|---|---|---|---|---|
Buys | 0 | ||||
Sells | 5 | -380K | 100% | $3.35 | -$1.27M |
Net | -5 | -380K | -100% | -$1.27M |
Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
---|---|---|---|---|---|
Rubric Capital Management LP | 10%+ Owner | $61.1M | Jun 17, 2024 | ||
Denise Scots-Knight | Chief Executive Officer, Director | $3.27M | -$463K | -12.4% | Jun 25, 2024 |
Charles Sermon | General Counsel | $873K | -$162K | -15.6% | Jun 25, 2024 |
Christine Fox | Chief Financial Officer | $443K | -$148K | -25% | Jun 25, 2024 |
John A. Lewicki | Chief Scientific Officer | $352K | -$84.4K | -19.3% | Jun 25, 2024 |
Michael S. Wyzga | Director | $145K | Jun 17, 2024 | ||
Alexandra Hughes-Wilson | Chief Patient Access and Commercial Planning | $117K | -$413K | -77.9% | Jun 25, 2024 |
Jeremy Bender | Director | $95.5K | Jun 17, 2024 | ||
Anders Ekblom | Director | $83.8K | Feb 8, 2024 | ||
Daniel Shames | Director | $45.5K | Feb 8, 2024 | ||
Deepika Pakianathan | Director | $45.5K | Feb 8, 2024 | ||
Marc J. Yoskowitz | Director | $45.5K | Feb 8, 2024 | ||
Pierre Jacquet | Director | $45.5K | Feb 8, 2024 | ||
Annalisa Jenkins | Director | $45.5K | Feb 8, 2024 | ||
Justin Hunter Roberts | Director | Jan 1, 2024 |
Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
---|